Daptomycin

Description

Daptomycin · CAS 103060-53-3 · C72H101N17O26. UNII NWQ5N31VKK.

Identification

Computed Descriptors

Regulatory Status

GHS Hazard Classification

Documented Uses

• Use (kg; approx.) in Germany (2009): >10
• Consumption (g per capita; approx.) in Germany (2009): 0.000122
• Daptomycin is a cyclic lipopeptide antibiotic derived from the organism Streptomyces roseosporus. Daptomycin treats various bacterial infections caused by gram-positive bacteria, including methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci (VRE). Daptomycin is prescribed for various FDA-approved and off-label clinical uses.
• Daptomycin is an intravenously administered, broad spectrum antibiotic used to treat complex skin and tissue infections, endocarditis and bacteremia. Daptomycin is associated with a low to modest rate of serum enzyme elevations during therapy, but is a very rare cause of clinically apparent liver injury.
• Breast Feeding; Lactation; Anti-Infective Agents; Antibacterial Agents; Peptides, Cyclic; Lipopeptides
• Substances that inhibit the growth or reproduction of BACTERIA.

Synonyms

DAPTOMYCIN; Cidecin; 103060-53-3; Cubicin; Daptomycinum; Daptomycine; Dapcin; Cubicin Rf; NWQ5N31VKK; DAPZURA RT; LY-146032; DTXSID1041009; LY146032; LY 146032; LY-164032; CHEBI:600103

Frequently Asked Questions

What are the CAS number and molecular formula of Daptomycin?

CAS 103060-53-3; molecular formula C72H101N17O26; molecular weight — g/mol.

What other names is Daptomycin known by?

DAPTOMYCIN, Cidecin, 103060-53-3, Cubicin, Daptomycinum, Daptomycine.

Is Daptomycin classified as hazardous?

2.4% of GHS notifications report no hazard classification (1 of 42).

Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.